World-Class CDMO Services for Japan
Global Contract Manufacturing Organizations Pharmaceutical Support for Japan’s Pharma Industry
Shilpa Pharma is a leading CDMO in India, providing end-to-end services for Japan pharmaceutical innovators, including chemical development, API and intermediate manufacturing, formulation development, biologics, peptides, polymers, and continuous flow chemistry. Our expertise spans complex chemistries, such as cryogenic reactions, asymmetric synthesis, high-potent APIs, and onco/cytotoxic intermediates, ensuring high-quality, compliant, and cost-effective solutions.
We support global pharma companies, including Japanese pharmaceutical innovators, with reliable, tailored, and scalable solutions that meet the most stringent regulatory standards, including USFDA, EU GMP, PMDA, ANVISA, COFEPRIS, KFDA, and TGA.
As a full-scale CDMO, Shilpa Pharma provides end-to-end project support, from R&D, process optimization, and analytical studies to commercial-scale API and formulation manufacturing. Backed by decades of experience in oncology, antiviral, CNS, cardiovascular, immunology, and specialty segments, we ensure seamless project execution regardless of scale or complexity.
Partner with Shilpa Pharma today and accelerate product development with confidence, compliance, and unmatched manufacturing performance.
Our CDMO Specialties
- High pressure reaction with Pd/Ru/Rd etc., Hydrogenation
- Brominating/Chlorination
- Cyanation
- Electro-chemical reactions
- Asymmetric synthesis
- Cryogenic reactions (up to -90°C)
- Boron Chemistry
- Hydrogenation including asymmetric capabilities
- Butyl Lithium Reaction
- Chiral Synthesis
- Cyclopropane Chemistry
- Grignard Reaction
- Indole Chemistry
- Nucleoside Chemistry
- Purine Chemistry
- Pyridine Chemistry
- Pyrimidine Chemistry
- Steroid Chemistry
- Oxidation and reduction reactions
- Pressure reactions
- Enzymatic reactions
- Use of phase transfer catalyst
- Cytotoxic (Onco) products Can handle with isolators.
Have Questions? We’re Here to Help
Get a Quote
Happy Customers
Projects Successfully Completed
Established
PhD Experts Driving R&D Excellence
Team Size
World-Class API Manufacturing Sites
Global Audits Successfully Completed
Comprehensive CDMO Service Offerings
Shilpa Pharma Globally Accredited CDMO Partner
With world-class regulatory approvals, advanced infrastructure, and proven expertise, Shilpa Pharma, a leading CDMO in India, supports Japanese pharmaceutical innovators and global distributors. Our strong commitment to quality, compliance, and confidentiality enables seamless collaborations and successful outcomes across regulated international markets, including Japan.
Why Shilpa Pharma is Your Trusted CDMO Partner Across the Globe
As a globally accredited CDMO based in India, Shilpa Pharma supports Japanese pharmaceutical companies with end-to-end, compliant, and cost-effective manufacturing solutions. Our expertise in complex chemistries, advanced formulations, and regulated market requirements ensures consistent quality and reliable supply.
End-to-End CDMO Solutions
From route scouting to GMP manufacturing, we cover every stage of drug development.
State-of-the-Art R&D
Advanced laboratories for formulation, biologics, and peptide research.
Global Quality Standards
GMP-compliant facilities ensuring regulatory-ready production.
Advanced Manufacturing Capabilities
High-potent APIs, continuous flow chemistry, and scalable processes.
Sustainable & Compliant Operations
Environmentally responsible practices with stringent safety protocols.
Trusted by Pharma Innovators
Reliable partnerships delivering complex projects on time and within budget.
CUSTOM CONTRACT MANUFACTURING TO JAPAN PHARMA
Shilpa Pharma has earned its position as a leading CMO Contract Manufacturing Organization by combining scientific strength, global compliance, and reliable production capabilities that pharmaceutical companies trust. Our custom manufacturing services deliver precision, quality, and regulatory compliance at every stage, supporting partners from small-batch production to high-volume commercial manufacturing.
Our state-of-the-art facilities are equipped with advanced process technologies and robust quality systems, enabling strict adherence to international regulatory requirements. Each project is managed with transparency and control, ensuring consistent quality, supply reliability, and cost-effective outcomes for global markets, including Japan.
- Precision & Compliance: Rigorous quality checks aligned with global regulatory standards.
- Advanced Facilities: Capabilities for complex APIs, high-potency products, and specialized formulations
- End-to-End Manufacturing: Seamless support from tech transfer to commercial supply
CONTRACT DEVELOPMENT
,Shilpa Pharma’s custom development services provide innovative, compliant, and scalable pharmaceutical solutions tailored to client-specific requirements. Leveraging advanced R&D expertise and GMP-certified infrastructure, we support every stage, from route scouting and process optimization to formulation development and pilot-scale manufacturing.
As a trusted global CMO, we focus on long-term partnerships by offering flexible development strategies aligned with molecule complexity and regulatory pathways. Our scientific teams ensure smooth tech transfer, optimized processes, and regulatory-ready solutions that accelerate timelines without compromising quality or confidentiality.
Questions & Answers
Our FAQ's
Everything You Need to Know About API Manufacturing in India at Shilpa Pharma
How does Shilpa Pharma support Japanese pharmaceutical companies?
Shilpa Pharma supports Japanese pharmaceutical companies with PMDA-compliant CDMO services, offering end-to-end development and manufacturing from India while ensuring quality, confidentiality, and supply reliability.
Is Shilpa Pharma compliant with PMDA requirements?
Why do Japanese pharma companies choose an India-based CDMO?
India offers cost-efficient, high-quality pharmaceutical manufacturing. Shilpa Pharma combines this advantage with global regulatory compliance, making it a trusted CDMO partner for Japanese pharmaceutical companies.
What CDMO services does Shilpa Pharma offer for the Japan market?
We provide custom development, API and formulation manufacturing, process optimization, and commercial-scale production tailored to the regulatory and quality expectations of the Japanese market.
Can Shilpa Pharma handle complex APIs for Japanese pharma companies?
Yes. We specialize in complex chemistries, oncology APIs, and high-potency products, delivering PMDA-ready manufacturing for Japanese pharmaceutical innovators.
How does Shilpa Pharma ensure quality and confidentiality for Japanese clients?
Our quality systems, data integrity practices, and strict confidentiality protocols ensure Japanese clients receive secure, compliant, and reliable CDMO services.
Does Shilpa Pharma support long-term partnerships with Japanese companies?
Yes. We focus on building long-term, trust-based partnerships aligned with Japanese business values, offering transparency and consistent communication throughout the project lifecycle.
Can Shilpa Pharma support technology transfer for Japan-focused products?
Our scientific teams ensure smooth technology transfer, validated processes, and scalable manufacturing to support successful product launches in Japan.
Which therapeutic areas does Shilpa Pharma support for the Japanese market?
We support oncology, antiviral, CNS, cardiovascular, immunology, and specialty therapeutics for Japanese pharmaceutical companies.
Why is Shilpa Pharma a trusted CDMO partner for Japan?
Shilpa Pharma combines PMDA-aligned compliance, advanced manufacturing infrastructure, and decades of scientific expertise, making us a preferred CDMO partner for Japanese pharma companies.
Countries We Serve in
Learn About CMO Contract Manufacturing Organization
Leading CMO Contract Manufacturing Organization in Japan
Shilpa Pharma is recognized globally as one of the most reliable and high-performing CMO Contract Manufacturing Organizations, trusted by leading pharmaceutical companies for our uncompromising quality, regulatory excellence, and advanced manufacturing capabilities. With decades of expertise and world-class facilities, we help partners accelerate product development, reduce production costs, and bring life-saving medicines to market with confidence.What Is a CMO Contract Manufacturing Organization?
A CMO (Contract Manufacturing Organization) is a specialised partner that supports pharmaceutical and biotech companies by handling various stages of drug production. This includes formulation development, scale-up, analytical testing, API manufacturing, and commercial-scale production. CMOs enable companies to focus on research, innovation, and market expansion while the manufacturing is handled by a trusted expert.Why Choose Shilpa Pharma as Your CMO Partner in Japan?
Shilpa Pharma offers a unique blend of scientific strength, regulatory compliance, and manufacturing precision. Our facilities are approved by major global authorities including USFDA, EU GMP, PMDA, TGA, COFEPRIS, KFDA, and ANVISA—ensuring every product meets the highest international standards.
End-to-end manufacturing support from development to commercial production
Expertise in complex and high-potency APIs
Strong track record of confidentiality and on-time delivery
Dedicated technical and regulatory teams for seamless project execution
Flexible, scalable solutions that align with partner needs
Your Trusted Global Manufacturing Partner
Whether you are looking to outsource a single step of production or an entire product line, Shilpa Pharma provides dependable, transparent, and efficient CMO services designed to support your growth.Ready to work with a world-class manufacturing partner?
Connect with Shilpa Pharma today to explore tailored CMO solutions for your pharmaceutical needs.
